User:Ybs.Umich/sandbox

Source: Wikipedia, the free encyclopedia.
Figure1. Salicylic acid is acetylated to form aspirin

Acetylation (or in

Deacetylation
is the removal of the acetyl group.)

Acetylation refers to the process of introducing an acetyl group (resulting in an

hydroxyl
group with an acetyl group (CH3 CO) yields a specific ester, the acetate. Acetic anhydride is commonly used as an acetylating agent reacting with free hydroxyl groups. For example, it is used in the synthesis of aspirin and heroin.

Acetylation of proteins

Introduction

Acetylation is an important modification of proteins in

lipidation and proteolysis before becoming the mature protein product.[5] Acetylation occurs as a co-translational and post-translational modification of proteins, for example, histones, p53, and tubulins. Among these proteins, chromatin proteins and metabolic enzymes are highly represented, indicating that acetylation has a considerable impact on gene expression and metabolism. In bacteria, 90% of proteins involved in central metabolism of Salmonella enteric are acetylated.[6]

N-terminal Acetylation, an Important Example of Co-translational Acetylation on Proteins

General Introduction of N-terminal Acetylation

N-terminal acetylation is one of the most common co-translational covalent modifications of proteins in

archaebacteria
are also modified by N-terminal acetylation.

Figure 2.


N-terminal Acetylation is catalyzed by a set of enzyme complexes, the N-terminal acetyltransferases (NATs). NATs transfer an acetyl group from

N-termini, and the acetylation was found to be irreversible so far. [8]

N-terminal Acetyltransferases

In total, there are six different NATs have been reported in humans, they are NatA, NatB, NatC, NatD, NatE and NatF. Each of these different enzyme complexes is specific for different amino acids or amino acid sequences which is show in the following table.

Table 1. The Composition and Substrate specificity of NATs

NAT Subunits Substrates
NatA Naa10p (Ard1p) Naa5p (Nat1p)
N-termini
NatB Naa20p (Nat3p) Naa25p (Mdm20p)
N-termini
NatC Naa30p (Mak3p) Naa35p (Mak10p) Naa40p (Nat5p)
N-termini
NatD Naa40p (Nat4p)
N-termini
NatE Naa50p (Nat5p)
N-termini
NatF Naa60p
N-termini
NatA

NatA is composed of two subunits, the catalytic

eukaryotes. Both of the gene hNAA10, hNAA15, which is from human and the orthologous NAA11 and NAA16, which is from bacterial, could make functional gene products, which might form different active hNatA complexes. At least four possible hNatA complexes are formed with the hNaa10p-hNaa15p dimer, which makes NatA to be considered to the most abundant Nat.[9]

NatA acetylates

N-termini after the initiator methionine is removed by methionine amino-peptidases. These amino acids are more frequently expressed in the N-terminal of proteins in eukaryotes, so NatA is the major NAT corresponding to the whole number of its potential substrates.[10]

Several different interaction partners are involved in the N-terminal acetylation by NatA. Huntingtin interacting protein K (HYPK) interacts with hNatA on ribosome to affect the N-terminal acetylation of a subset of NatA substrates. Subunits hNaa10p and hNaa15p will increase the tendency for aggregation of Huntingtin if HYPK is depleted. Hypoxia-inducible factor (HIF)-1αhas also been found to interact with hNaa10p to inhibit hNaa10p-mediated activation of β-catenin transcriptional activity.[11]

Figure 3. The red chains are subunits Naa5p and the blue chains are subunits Naa10p.[12]
NatB

NatB complexes are composed with the catalytic subunit Naa20p and the auxiliary subunit Naa25p, which are both found in yeast and humans. In yeast, all the NatB subunits are ribosome-associated; but in humans, NatB subunits are both found to be ribosome-associated and non-ribosomal form. NatB acetylates the N-terminal methionine of substrates starting with Met-Glu-, Met-Asp-, Met-Asn- or Met-Gln- N termini.

NatC

NatC complex consists of one catalytic subunit Naa30p and two auxiliary subunits Naa35p and Naa38p. All three subunits are found on the ribosome in yeast, but they are also found in non-ribosomal NAT forms like Nat2. NatC complex acetylates the N-terminal methionine of substrates Met-Leu-, Met-Ile-, Met-Trp- or Met-Phe N-termini.

NatD

NatD is only composed with the catalytic unit Naa40p and Naa40p and it is conceptually different form the other NATs. At first, only two substrates, H2A and H4 have been identified in yeast and humans. Secondly, the substrate specificity of Naa40p lies within the first 30-50 residues which are quite larger than the substrate specificity of other NATs. The acetylation of

histones by NatD is partially associate with ribosomes and the amino acids substrates are the very N-terminal residues, which makes it different from Lysine N-acetyltransferases (KATs).[13]

NatE

NatE complex consists with subunit Naa50p and two NatA subunits, Naa10p and Naa15p. The N terminus of Naa50p substrates is different from those acetylated by the NatA activity of Naa10p.[14]

NatF

NatF is a newly identified NAT in 2011, which is composed with Naa60p enzyme. Till now, NatF is only found in higher eukaryotes, but not in lower eukaryotes. Compared to yeast, NatF contributes to the higher abundance of N-terminal acetylation in humans. NatF complex acetylates the N-terminal methionine of substrates Met-Lys-, Met-Leu-, Met-Ile-, Met-Trp- and Met-Phe N termini which are partly overlapping with NatC and NatE.[15]

Function of N-terminal Acetylation

N-terminal acetylation affects protein stability

N-terminal acetylation of proteins can affect protein stability but the results and mechanism is not very clear till now.

protein degradation. [17] But several studies have shown that the N-terminal acetylated protein have a similar degradation rate as proteins with a non-blocked N-terminus.[18]

N-terminal acetylation affects protein localization

N-terminal acetylation has been shown that it can steer the localization of proteins. Arl3p contains a

GTPases, which is crucial for the organization of member traffic. [19] It requires its Nα-acetyl group for its targeting to the Golgi membrane by the interaction with Golgi membrane-residing protein Sys1p. If the Phe or Tyr is replaced by an Ala at the N-terminal of Arl3p, it can no longer localized to the Golgi membrane, indicating that Arl3p needs its natural N-terminal residues which could be acetylated for proper localization. [20]

N-terminal acetylation affects metabolism and apoptosis

Protein N-terminal acetylation has also been proved to relate with cell cycle regulation and apoptosis with protein knockdown experiments. Knockdown of the NatA or the NatC complex leads to the induction of

cell apoptosis.[22]

N-terminal acetylation affects protein synthesis

Ribosome proteins play an important role in the protein synthesis, which could also be N-terminal acetylated. The N-terminal acetylation of the ribosome proteins may have an effect on protein synthesis. A decrease of 27% and 23% in the protein synthesis rate was observed with NatA and NatB deletion strains. A reduction of translation fidelity was observed in the NatA deletion strain and a defect in ribosome was noticed in the NatB deletion strain.[23]

N-terminal Acetylation in Cancer

NATs have been suggested to act as both onco-proteins and tumor suppressors in human cancers, and NAT expression may be increased and decreased in cancer cells. Ectopic expression of hNaa10p increased cell proliferation and up regulation of gene involved in cell survival proliferation and metabolism. Overexpression of hNaa10p was in the urinary bladder cancer, breast cancer and cervical carcinoma.[24] But a high level expression of hNaa10p could also suppress tumor growth and a reduced level of expressed hNaa10p is associated with a poor prognosis, large tumors and more lymph node metastases.

Table 2. Overview of the expression of NatA subunits in various cancer tissues[25]

Nat subunits Cancer tissue Expression pattern
hNaa10p lung cancer, breast cancer, colorectal cancer, hepatocellular carcinoma high in tumors
hNaa10p lung cancer, breast cancer, pancreatic cancer, ovarian cancer loss of heterozygosity in tumors
hNaa10p
gastric cancer, lung cancer
 high in primary tumors, but low with lymph node metastases
hNaa10p
Non-small cell lung cancer
 low in tumors
hNaa15p
gastric cancer
 high in tumors
hNaa15p neuroblastoma high in advanced stage tumors
hNaa11p hepatocellular carcinoma loss of heterozygosity in tumors

Lysine acetylation

Proteins are typically acetylated on lysine residues and this reaction relies on acetyl-coenzyme A as the acetyl group donor. In

gene regulation. Typically, these reactions are catalyzed by enzymes with histone acetyltransferase (HAT) or histone deacetylase (HDAC) activity, although HATs and HDACs can modify the acetylation status of non-histone proteins as well.[26] See main page on Histone acetylation and deacetylation
.

Lysine acetylation

The regulation of transcription factors, effector proteins,

phosphatases. Not only can the acetylation state of a protein modify its activity but there has been recent suggestion that this post-translational modification may also crosstalk with phosphorylation, methylation, ubiquitination, sumoylation, and others for dynamic control of cellular signaling.[28] The regulation of tubulin protein is an example of this in mouse neurons and astroglia.[29][30] A tubulin acetyltransferase is located in the axoneme
, and acetylates the α-tubulin subunit in an assembled microtubule. Once disassembled, this acetylation is removed by another specific deacetylase in the cell cytosol. Thus axonemal microtubules, which have a long half-life, carry a "signature acetylation," which is absent from cytosolic microtubules that have a shorter half-life.

The discovery of

posttranslational acetylation
. In the following examples, we choose the following proteins that are important in biology that regulate the important signal transduction in biology by acetylation of proteins. In addition, the acetylation regulation on those proteins also related to human diseases and has a potential for the development for therapy.

Important examples of lysine acetylation in proteins

p53

Background information

oncoprotein Mdm2. Studies suggested that Mdm2 will form a complex withe p53 and prevent it from binding to specific p53-responsive genes.[31][32]

Acetylation of p53

The acetylation of p53 is in dispensable for its activation. It has been reported that the acetylation level of p53 will increase significantly when cell undergo stress. There are three major acetylation site on p53: K164, K120 and C terminus.

proapoptotic functions.[35]

p53 acetylation site
Therapeutic implications for cancer therapy

Since the major function of

Nutlin-3[36] is a small molecule designed to target p53 and Mdm2 interaction that kept p53 from deactivation.[37] Reports also shown that the cancer cell under the Nutilin-3a treatment, acetylation of lys 382 was observed in the c-terminal of p53.[38][39]

Microtubule

Background information

The structure of

chromosomes in cell division.[41][42]


Formation of Microtubule
Acetylation of tubulin

The acetylated residue of α-

microtubules. The active site residues D157 and C120 of α-TAT1 are responsible for the catalysis because of the shape complementary to α-Tubulin. In addition, some unique structural features such as β4-β5 hairpin, C-terminal loop, and α1-α2 loop regions are important for specific α-Tubulin molecular recognition.[43] The reverse reaction of the acetylation is catalyzed by histone deacetylase 6.[44]

Acetylation tubulin
Therapeutic implications for cancer therapy

Since the

taxanes will destabilize and stabilize tubulin respective and result in the anomaly of cell division.[46] The identification of the crystal structure of acetylation ofα-tubulin acetyl-transferase (α-TAT) also shields a light on the discovery of small molecule that could modulate the stability or de-polymerization of tubulin. In other words, by targeting α-TAT, it is possible to prevent the tubulin form acetylation and result in the destabilization of tubulin, which is a similar mechanism for tubulin destabilizing agents. [47]

STAT3

Background information

Signal transducer and activator of transcription 3 (

tumor suppressor.[48]

Acetylation of STAT3

The acetylation of Lys685 of

oncogenes. The acetylation of STAT3 is catalyzed by histone acetyltransferase p300, and reversed by type 1 histone deacetylase. The lysine acetylation of STAT3 is also elevated in cancer cells.[49]


Structure and acetylation residue of STAT3
Therapeutic implications for cancer therapy

Since the acetylation of

chemoprevention and chemotherapy is a promising strategy. This strategy is supported by treating resveratrol, an inhibitor of acetylation of STAT3, in cancer cell line reverses aberrant CpG island methylation.[50]

Acetylation of wood

Since the beginning of the 20th century, acetylation of wood was researched as a method to upgrade the durability of wood in resistance against rotting processes and molds. Secondary benefits include the improvement of dimensional stability, improved surface hardness, and no decrease in mechanical properties due to the treatment. The physical properties of any material are determined by its chemical structure. Wood contains an abundance of chemical groups called “free hydroxyls”. Free hydroxyl groups adsorb and release water according to changes in the climatic conditions to which the wood is exposed. This is the main reason why wood swells and shrinks. It is also believed that the digestion of wood by enzymes initiates at the free hydroxyl sites – which is one of the principal reasons why wood is prone to decay.

Acetylation changes the free hydroxyls within the wood into acetyl groups. This is done by reacting the wood with acetic anhydride, which comes from acetic acid (known as vinegar when in its dilute form). When the free hydroxyl group is transformed to an acetyl group, the ability of the wood to absorb water is greatly reduced, rendering the wood more dimensionally stable and, because it is no longer digestible, extremely durable.

See also

References

  1. PMID 19608861
    .
  2. PMID 22309199
    .
  3. ^ Brook, Tom. "Protein Acetylation: Much More than Histone Acetylation". Cayman Chemical.
  4. PMID 18188474
    .
  5. ISBN 0-07-138901-6
    .
  6. PMID 20167786
    .
  7. PMID 21750686.{{cite journal}}: CS1 maint: unflagged free DOI (link
    )
  8. PMID 22405572
    .
  9. PMID 19660096. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)CS1 maint: unflagged free DOI (link
    )
  10. PMID 19420222
    .
  11. PMID 20154145. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help
    )
  12. PMID 23912279
    .
  13. doi:10.1371/journal.pone.0024713
    .
  14. PMID 14517307. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help
    )
  15. PMID 21750686.{{cite journal}}: CS1 maint: unflagged free DOI (link
    )
  16. PMID 22718636. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help
    )
  17. PMID 6095265
    .
  18. PMID 20110468
    .
  19. PMID 15077113
    .
  20. PMID 19398576. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help
    )
  21. PMID 21351257
    .
  22. PMID 21854985
    .
  23. PMID 21184851
    .
  24. PMID 19287988
    .
  25. PMID 22391571
    .
  26. PMID 17681659.{{cite journal}}: CS1 maint: multiple names: authors list (link
    )
  27. PMID 16289629.{{cite journal}}: CS1 maint: multiple names: authors list (link
    )
  28. PMID 18722172
    .
  29. PMID 2736326
    .
  30. PMID 3733880. {{cite journal}}: URL–wikilink conflict (help
    )
  31. ISBN 0815332181
    .
  32. ISBN 978-0815342205
    .
  33. PMID 21748595
    .
  34. PMID 18485870
    .
  35. PMID 19265193
    .
  36. PMID 14704432
    .
  37. PMID 18834305
    .
  38. PMID 23666059
    .
  39. PMID 18451145
    .
  40. ISBN 0198599560. {{cite book}}: |first= has generic name (help); Unknown parameter |coauthors= ignored (|author= suggested) (help
    )
  41. ISBN 978-1429234139
    .
  42. ISBN 978-1588292940. {{cite book}}: |first= has generic name (help
    )
  43. PMID 23071314. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help
    )
  44. PMID 12024216
    .
  45. ISBN 978-3540690368. {{cite book}}: |first= has generic name (help); |first= missing |last= (help)CS1 maint: multiple names: authors list (link
    )
  46. ISBN 978-1609133450. {{cite book}}: |first= has generic name (help)CS1 maint: multiple names: authors list (link
    )
  47. PMID 23071314. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help
    )
  48. ISBN 978-0815342151.{{cite book}}: CS1 maint: multiple names: authors list (link
    )
  49. PMID 15653507
    .
  50. PMID 22547799
    .

Category:Organic reactions Category:Proteins Category:Posttranslational modification

Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Ybs.Umich/sandbox&oldid=1168401832"